Skip to content
Saturday, 24 October 2026RSS
APAC Capital Brief

Institution record

Trive Invest

PT Trive Invest Futures

Risk level not supplied0 of 1 licences marked regulated
Source score
3.0
Warnings
0
Comments
0

Licence records

Licences within our coverage (institutions licensed across asia-pacific and the middle east) are listed first. Check each one on the regulator's own register.

RegulatorLicence no.StatusLicensed entityDate
In our coverage
Indonesia Commodity & Derivatives Exchange
042/SPKB/ICDX/Dir/IX/2010No licenceInter Pan Pasifik Futures, PT—

Peer regulatory & risk comparison

Side-by-side supervisory and risk benchmark comparing Trive Invest against peer institutions in our institutions licensed across asia-pacific and the middle east dataset.

Full directory →
InstitutionPrimary regulatorsRegulated / totalRisk classificationSource scoreWarnings
Trive Invest (this record)
ICDX
0 / 1Risk level not supplied3.00
Agrodana Futures
Commodity Futures Trading Regulatory Agency of Indonesia (BAPPEBTI)ICDX
3 / 3Risk level not supplied1.00
MagnetFX
ICDXICDX
2 / 2Risk level not supplied6.50
GIB
Commodity Futures Trading Regulatory Agency of Indonesia (BAPPEBTI)ICDX
2 / 2Risk level not supplied5.00
Inter Pan
ICDXICDX
2 / 2Risk level not supplied5.00
Phillip Futures
ICDXCommodity Futures Trading Regulatory Agency of Indonesia (BAPPEBTI)
2 / 2Risk level not supplied5.00

Trive Invest: institutional due diligence FAQ

Key supervisory, licensing, and counterparty verification questions generated from the dataset.

What is Trive Invest's regulatory licence status and supervisory authorisation?

In our imported dataset, Trive Invest (legal entity reference: PT Trive Invest Futures) holds 1 recorded licence entry, of which 0 carry a "regulated" status and 0 are marked regulated or registered: ICDX (Indonesia Commodity & Derivatives Exchange) — licence 042/SPKB/ICDX/Dir/IX/2010, status: no licence. Institutional due diligence requires verifying that the exact legal entity on your counterparty agreement matches the licensed entity name and registration number on the official ICDX public register.

Which of Trive Invest's jurisdictions and licences fall within this site's regulatory coverage?

This directory focuses on institutions licensed across asia-pacific and the middle east. 1 of Trive Invest's 1 licence records fall directly within this jurisdictional mandate: ICDX (licence 042/SPKB/ICDX/Dir/IX/2010, no licence, entity: Inter Pan Pasifik Futures, PT). Always confirm whether client money segregation and statutory investor compensation schemes apply to the specific subsidiary onboarding your account.

What is Trive Invest's institutional risk classification, enforcement exposure, and score profile?

Trive Invest carries a "risk level not supplied" classification in the source dataset, alongside composite 5-dimension ratings out of 10 (overall: 3.0, risk & licensing: 3.0, brand: 3.0, market influence: 3.0, user reputation: 0.0). The record flags 0 regulatory warning or complaint counts and 1 licence record with elevated status flags (ICDX: no licence). Because these figures reflect imported source fields rather than primary audit findings, compliance teams should review primary enforcement bulletins directly.

What operational due diligence steps apply to Trive Invest's platforms, entity structure, and complaints?

Before allocating capital or executing trades with Trive Invest, institutional and retail allocators should: (1) confirm the domain (fxinterpan.com) against regulator-approved domains to guard against clone firms; (2) verify whether any of the 0 recorded warning/complaint entries or 0 user comments involve withdrawal restrictions or scope violations; and (3) confirm the dispute-resolution ombudsman tied to ICDX.

Editorial briefings and compliance research from APAC Capital Brief relevant to Trive Invest's supervisory scope.

All research →

APAC Semiconductor Capex

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Foreign Institutional Flow Attribution & Balance-Sheet Positioning (10.0% GBI-EM Maximum Index Weight Benchmark)

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing weekly net foreign bu

Read briefing →

ASEAN & HKEX Capital Flows

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Return on Equity (ROE) vs. Cost of Equity & Buyback Yield Math (10.0% GBI-EM Maximum Index Weight Benchmark)

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing unwinding strategic c

Read briefing →

BOJ & Yen Rates

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Sovereign Yield Curve Repricing & OIS Swap Spreads (10.0% GBI-EM Maximum Index Weight Benchmark)

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing 2s10s and 10s30s curv

Read briefing →

TSE Governance & Equities

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices: Foundry Wafer Capacity, Packaging Bottlenecks & Capex ROI Audit (10.0% GBI-EM Maximum Index Weight Benchmark)

India Fully Accessible Route (FAR) Sovereign Bonds in Global Bond Indices (INDIA-FAR-BONDS) stands at 10.0% (GBI-EM Maximum Index Weight) (Source: Reserve Bank of India (RBI), 2026-10-20), governing CoWoS-L interposer al

Read briefing →